Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.58 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 4/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.54 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.53 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.52 |
| ▸ | CALCR | P30988 | 1/20 | 0.52 |
| ▸ | MC4R | P32245 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30753758 | 0.94 | C5AR1 (0.63) | NMUR2NMUR1C5AR1F2RAMP3 | |
| SCHEMBL30233422 | 0.92 | C5AR1 (0.58) | NMUR2NMUR1C5AR1F2OPRM1 | |
| SCHEMBL30788367 | 0.92 | F2 (0.56) | NMUR2NMUR1C5AR1F2EPHA2 | |
| SCHEMBL29843005 | 0.91 | C5AR1 (0.58) | NMUR2NMUR1C5AR1F2RAMP3 | |
| SCHEMBL30233565 | 0.89 | C5AR1 (0.59) | NMUR2NMUR1C5AR1F2OPRM1 | |
| SCHEMBL30233281 | 0.89 | C5AR1 (0.63) | NMUR2NMUR1C5AR1F2RAMP3 | |
| SCHEMBL30788370 | 0.89 | TFPI (0.59) | NMUR2NMUR1C5AR1F2OPRM1 | |
| SCHEMBL30233814 | 0.89 | C5AR1 (0.63) | C5AR1F2RAMP3CALCRMC4R | |
| SCHEMBL30788362 | 0.87 | F2 (0.56) | NMUR2NMUR1C5AR1F2 | |
| SCHEMBL30753760 | 0.87 | C5AR1 (0.64) | NMUR2NMUR1C5AR1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041740-A1 | SKIN PEEL COMPOSITIONS | GLO PHARMA INC (US) | 2024-02-08 | — | — | US | disclosed |